| Literature DB >> 35164403 |
Izabela M Domańska1, Anna Zgadzaj2, Sebastian Kowalczyk3, Aldona Zalewska3, Ewa Oledzka1, Krystyna Cieśla4, Andrzej Plichta3, Marcin Sobczak1,5.
Abstract
Aliphatic polyesters are the most common type of biodegradable synthetic polymer used in many pharmaceutical applications nowadays. This report describes the ring-opening polymerization (ROP) of l-lactide (L-LA), ε-caprolactone (CL) and glycolide (Gly) in the presence of a simple, inexpensive and convenient PEG200-BiOct3 catalytic system. The chemical structures of the obtained copolymers were characterized by 1H- or 13C-NMR. GPC was used to estimate the average molecular weight of the resulting polyesters, whereas TGA and DSC were employed to determine the thermal properties of polymeric products. The effects of temperature, reaction time, and catalyst content on the polymerization process were investigated. Importantly, the obtained polyesters were not cyto- or genotoxic, which is significant in terms of the potential for medical applications (e.g., for drug delivery systems). As a result of transesterification, the copolymers obtained had a random distribution of comonomer units along the polymer chain. The thermal analysis indicated an amorphous nature of poly(l-lactide-co-ε-caprolactone) (PLACL) and a low degree of crystallinity of poly(ε-caprolactone-co-glycolide) (PCLGA, Xc = 15.1%), in accordance with the microstructures with random distributions and short sequences of comonomer units (l = 1.02-2.82). Significant differences in reactivity were observed among comonomers, confirming preferential ring opening of L-LA during the copolymerization process.Entities:
Keywords: aliphatic polyesters; biodegradable polymers; bismuth(III) 2-ethylhexanoate; poly(l-lactide); poly(l-lactide-co-ε-caprolactone); poly(ε-caprolactone); poly(ε-caprolactone-co-glycolide); ring opening polymerization
Mesh:
Substances:
Year: 2022 PMID: 35164403 PMCID: PMC8840241 DOI: 10.3390/molecules27031139
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Homo- and copolymerization of CL, Gly and L-LA. Temperature-dependent optimization (24 h, PEG200:BiOct3 = 1:1).
| Sample | Molar Ratio | Temp. (°C) | Yield (%) |
| |||
|---|---|---|---|---|---|---|---|
|
PLA | L-LA = 1.0 | 110 | 73 | 100 | 11.7 | 15.5 | 1.23 |
| L-LA = 1.0 | 130 | 85 | 100 | 13.9 | 15.3 | 1.64 | |
|
PCL | CL = 1.0 | 110 | 50 | 94 | 11.4 | 8.8 | 1.67 |
| CL = 1.0 | 130 | 68 | 100 | 12.2 | 6.9 | 2.33 | |
|
PLACL | L-LA = 0.45 | 110 | 64 | 99 (L-LA) | 13.6 | 7.3 | 2.50 |
| L-LA = 0.50 | 130 | 56 | 100 (L-LA) | 10.2 | 9.7 | 1.87 | |
|
CLGA | CL = 0.84 | 110 | 60 | 100 (Gly) | 11.5 | 6.8 | 2.59 |
| CL = 0.86 | 130 | 73 | 100 (Gly) | 10.3 | 11.8 | 1.66 |
a—calculated from 1H NMR; b—calculated from the feed ratio c—determined from GPC.
Figure 1GPC traces for the polymers synthesized in 110 °C (solid line) vs. 130 °C (dashed line).
Figure 2The polymerization kinetics of polymeric carriers (130 °C, PEG200:BiOct3 = 1:1).
Homo- and copolymerization of CL, Gly and L-LA. Catalyst content-dependent optimization (24 h, 130 °C (110 °C for PLA), monomer:PEG200 = 100:1).
| Sample | Monomer/ | Molar Ratio | Yield (%) | ||||
|---|---|---|---|---|---|---|---|
| PLA | 500 | L-LA = 1.0 | 90 | 98 | 12.1 | 12.3 | 1.29 |
| PCL | 400 | CL = 1.0 | 70 | 100 | 11.7 | 10.8 | 1.59 |
| PLACL | 300 | L-LA = 0.52 | 79 | 99 (L-LA) | 12.6 | 14.9 | 1.55 |
| PCLGA | 1000 | CL = 0.85 | 78 | 100 (Gly) | 11.8 | 10.4 | 1.75 |
a—calculated from 1H NMR; b—calculated from the feed ratio; c—determined from GPC.
Figure 3TGA (a) and DTGA (b) plots of the obtained polymeric carriers.
Thermal decomposition of polymeric matrices.
| Sample | Δ | Δ | |||||
|---|---|---|---|---|---|---|---|
| PLA | 0.02 | 98.77 | 304.5 | 371.2 | 394.6 | 377.9 | 414.9 |
| PCL | 0.01 | 100.00 | 351.4 | 408.8 | 434.4 | 413.3 | 464.5 |
| PLACL | 0.62 | 99.03 | 339.3 | 389.6 | 424.9 | 393.3 | 464.0 |
| PCLGA | 0.58 | 99.50 | 365.4 | 406.9 | 433.8 | 409.8 | 475.6 |
Thermal parameters of polymeric matrices determined from DSC.
| Sample | Δ | Δ | ||||||
|---|---|---|---|---|---|---|---|---|
| PLA | 54.4 | 104.6 | 102.1 | 158.9 | 156.9 | 15.5 | 51.4 | 33.9 |
| PCL | −62.9 | nd | nd | 60.8 | 55.7 | nd | 128.5 | 98.1 |
| PLACL | −12.3 | nd | nd | nd | nd | nd | nd | 0.0 c |
| PCLGA | −56.2 | −23.1 | −29.1 | 20.0 | 13.8 | 54.7 | 76.5 | 15.1 |
a—cold crystallization process; b—melting process; c—amorphous; nd—not detected.
Figure 4DSC thermograms of (a) PLA, (b) PCL, (c) PCLGA and (d) PLACL. DDSC curves in miniatures (determination of Tg).
Figure 51H NMR spectrum of PCLGA.
Figure 613C NMR spectrum of PLACL, region of carbonyl carbon atoms of ε-oxycaproyl and lactidyl units.
Chemical shifts in 1H NMR spectrum of PCLGA.
| Signal | δ [ppm] | Sequence |
|---|---|---|
| a | 4.79 | G |
| b | 4.73 | Cap |
| c | 4.68 | G |
| d | 4.64 | Cap |
| e | 4.60 | Cap |
| f | 4.16 | G |
| g | 4.06 | Cap |
Chemical shifts in 13C NMR spectrum of PLACL, region of carbonyl carbon atoms of ε-oxycaproyl and lactidyl units.
| Signal | δ [ppm] | Sequence |
|---|---|---|
| a | 173.59 | Cap |
| b | 173.45 | Cap L |
| c | 173.43 | L L |
| d | 172.86 | Cap |
| e | 172.79 | L L |
| f | 172.73 | Cap L |
| g | 172.71 | L L |
| h | 170.82 | Cap |
| i | 170.33 | Cap L L |
| j | 170.26 | Cap L |
| k | 170.21 | Cap |
| l | 170.09 | Cap |
| m | 170.06 | Cap |
| n | 160.73 | L L |
| o | 169.66 | Cap L |
| p | 169.57 | L L |
Structural characteristics of PLACL and PCLGA (synthesis parameters: 24 h, 130 °C).
| Kind of Copolymer/Molar Ratio | The Average Length of the Blocks |
|
|
|---|---|---|---|
| poly( | 0.70 | 1.07 | |
| poly(ε-caprolactone- | 0.96 | 1.33 |
lLe—experimental average length of lactyl blocks; lCLe—experimental average length of caproyl blocks; lGe—experimental average length of glycolyl blocks; R—randomization ratio; TII—yield of the second mode of transesterification.
Results of the umu-test and the NRU test in contrast to the untreated control at the highest concentrations of tested extracts [1 mg mL−1].
| Sample | Genotoxicity Assay | Cytotoxicity Assay | |
|---|---|---|---|
| Cells Viability ± SD [%] | |||
| PLA | 0.96 ± 0.02 | 0.75 ± 0.11 | 102 ± 2 |
| PCL | 0.94 ± 0.11 | 0.79 ± 0.08 | 100 ± 1 |
| PLACL | 0.87 ± 0.03 | 0.82 ± 0.14 | 108 ± 6 |
| PCLGA | 1.04 ± 0.11 | 0.78 ± 0.14 | 97 ± 4 |
a version without metabolic activation, b version with metabolic activation.